In:
Obstetrical & Gynecological Survey, Ovid Technologies (Wolters Kluwer Health), Vol. 76, No. 9 ( 2021-9), p. 521-523
Abstract:
(Abstracted from Lancet Gastroenterol Hepatol 2021;6:547–558) Ursodeoxycholic acid (UA) is a common treatment for intrahepatic cholestasis of pregnancy (ICP), and its use is supported by the Society for Maternal-Fetal Medicine. However, evidence of the benefit of UA to fetal and neonatal outcomes in this patient population is unclear.
Type of Medium:
Online Resource
ISSN:
1533-9866
,
0029-7828
DOI:
10.1097/01.ogx.0000792616.29408.2a
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2021
detail.hit.zdb_id:
391345-4
detail.hit.zdb_id:
2043471-6